A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
RasCal Therapeutics, Inc.
RasCal Therapeutics, Inc.
Frontier Medicines Corporation
National Cancer Institute (NCI)
Filamon LTD
AstraZeneca
Bristol-Myers Squibb
Seagen Inc.
Origin Sciences
National Institutes of Health Clinical Center (CC)
Seagen Inc.
Eli Lilly and Company
Tomsk National Research Medical Center of the Russian Academy of Sciences
Kivu Bioscience Inc.
NeoImmuneTech
Alterome Therapeutics, Inc.
Verastem, Inc.
Hoffmann-La Roche
EMD Serono
UMC Utrecht
Aveni Foundation
Boehringer Ingelheim
ViroMissile, Inc.
University of California, Davis
Massachusetts General Hospital
Erasca, Inc.
Jazz Pharmaceuticals
Sichuan Enray Pharmaceutical Sciences Company
AstraZeneca
Duke University
A2 Biotherapeutics Inc.
AstraZeneca
Arvinas Inc.
Essen Biotech
National Institutes of Health Clinical Center (CC)
A2 Biotherapeutics Inc.
Eli Lilly and Company
Poseida Therapeutics, Inc.
MacroGenics
Poitiers University Hospital
Revolution Medicines, Inc.
Pheon Therapeutics
Auricula Biosciences Inc.
City of Hope Medical Center
xCures
Daiichi Sankyo
SN BioScience
University of Nebraska
Takeda
Eli Lilly and Company
Zhejiang University